Excessive Daytime Sleepiness: Considerations for the Psychiatrist

Psychiatric Clinics of North America

Volumn 29, Issue 4, 2006, Pages 921-945

  Leibowitz, Scott M ^a   Brooks, Stephen N ^b   Black, Jed E ^b  

^a CDS   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT; METHAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; NEUROLEPTIC AGENT; OXYBATE SODIUM; PRAMIPEXOLE; ROPINIROLE;

AGITATION; ANAMNESIS; ANXIETY; AUTOMATISM; BEHAVIOR THERAPY; CANCER; CATALEPSY; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL SLEEP APNEA SYNDROME; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DAYTIME SOMNOLENCE; DEGENERATIVE DISEASE; DISEASE SEVERITY; DRUG EFFECT; EMOTIONAL STRESS; ENDOCRINE DISEASE; EPWORTH SLEEPINESS SCALE; FIBROMYALGIA; FRAGMENTED NOCTURNAL SLEEP; HEART PALPITATION; HOMEOSTASIS; HUMAN; HYPERSOMNIA; HYPNAGOGIC HALLUCINATION; IDIOPATHIC HYPERSOMNIA; IDIOPATHIC RECURRING STUPOR; MENSTRUAL RELATED HYPERSOMNIA; MENTAL DISEASE; NARCOLEPSY; NIGHT SLEEP; PARASOMNIA; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; POPULATION RESEARCH; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; RESTLESSNESS; REVIEW; RHEUMATIC DISEASE; SEDATION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING; SLEEP PARAMETERS; SLEEP TIME; SNORING; TREMOR; UPPER AIRWAY RESISTANCE SYNDROME;

CENTRAL NERVOUS SYSTEM DISEASES; DISORDERS OF EXCESSIVE SOMNOLENCE; DRUG THERAPY; FATIGUE; HUMANS; MENTAL DISORDERS; NEURODEGENERATIVE DISEASES; NOCTURNAL MYOCLONUS SYNDROME; POLYSOMNOGRAPHY; PSYCHIATRY; RECURRENCE; SLEEP APNEA, OBSTRUCTIVE; SLEEP DEPRIVATION; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 33751016362     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2006.09.004     Document Type: Review

References (134)

1. International Classification of Sleep Disorders. Diagnostic and coding manual, revised (1997), American Sleep Disorders Association, Rochester (MN)
2. Ohayon M.M., Priest R.G., Zulley J., et al. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 58 (2002) 1826-1833
3. National Sleep Foundation. Sleep in America Poll, 2002. Available at: http://www.sleepfoundation.org.
4. National Sleep Foundation. Sleep in America Poll, 2003. Available at: http://www.sleepfoundation.org.
5. Johns M.W. A new method of measuring sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
6. Hoddes E., Zarcone V., Smythe H., et al. Quantification of sleepiness: a new approach. Psychophysiology 10 (1973) 431-436
7. Rosenthal L., Roehr T.A., and Roth T. The sleep-wake activity inventory: a self-report measure of daytime sleepiness. Biol Psychiatry 34 (1993) 810-820
8. Richardson G., Carskadon M., Flagg W., et al. Excessive daytime sleepiness in man: multiple sleep latency measurements in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 45 (1978) 621-627
9. Chua L.W.Y., Yu N.C., Golish J.A., et al. Epworth sleepiness scale and the multiple sleep latency test: dilemma of the elusive link. Sleep 21 Suppl (1998) 184
10. U.S. Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 43 (1998) 88-97
11. Johns M.W., and Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep 20 (1997) 844-849
12. Carskadon M.A., and Dement W.C. Cumulative effects of sleep restriction on daytime sleepiness. Psychophysiology 18 (1981) 107-113
13. Littner M.R., Kushida C., Wise M., et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28 (2005) 113-121
14. Kakkanen J., Summala H., Partinen M., et al. Blink duration as an indicator of driver sleepiness in professional bus drivers. Sleep 22 (1999) 798-802
15. Banks S., Cacheside P., Lack L.C., et al. The maintenance of wakefulness test and driving simulator performance. Sleep 28 (2005) 1360-1361
16. Rosenthal L., Roehrs T.A., Rosen A., et al. Level of sleepiness and total sleep time following various time in bed conditions. Sleep 16 (1993) 226-232
17. Roehrs T.A., Shore E., Papineau K., et al. A two-week sleep extension in sleepy normals. Sleep 19 (1996) 576-582
18. Beers T. Flexible schedules and shift work: replacing the '9-to-5' workday?. Mon Labor Rev (2000) 33-40
19. Monk T.H. Shift work. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practices of sleep medicine. 3rd edition (2000), Saunders, Philadelphia 602-603
20. Akerstedt T. Sleepiness as a consequence of shift work. Sleep 11 (1988) 17-34
21. Budnick L.D., Lerman S.E., Baker T.L., et al. Sleep and alertness in a 12-hour rotating shift work environment. J Occup Med 36 (1994) 1295-1300
22. Czeisler C.A., Walsh J.K., Roth T., et al. Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med 353 (2005) 476-486
23. Philip P., Stoohs R., and Guilleminault C. Sleep fragmentation in normals. Sleep 17 (1994) 242-247
24. Chugh D.K., Weaver T.E., and Dinges D.F. Neurobehavioral consequences of arousals. Sleep 19 10 Suppl (1996) S198-S201
25. Gozal D., Wang M., and Pope D.W. Objective sleepiness measure in pediatric obstructive sleep apnea. Pediatrics 108 (2001) 693-697
26. Melendres C.S., Lutz J.M., Rubin E.D., et al. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics 114 (2004) 768-775
27. Golan N., Shahar E., Ravid S., et al. Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactive disorder. Sleep 27 (2004) 261-266
28. Rosen C.L., Storfer-Isser A., Taylor H.G., et al. Increased behavioral morbidity in school-aged children with sleep-disordered breathing. Pediatrics 114 (2004) 1640-1648
29. Chervin R.D., Archbold K.H., Dillon J.E., et al. Inattention, hyperactivity, and symptoms of sleep-disordered breathing. Pediatrics 109 (2002) 449-456
30. O'Brien L.M., Mervis C.B., Holbrook C.R., et al. Neurobehavioral implications of habitual snoring in children. Pediatrics 114 (2004) 44-49
31. Picchietti D.L., England S.J., Walters A.S., et al. Periodic limb movements disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 13 (1998) 588-594
32. Picchietti D.L., and Walters A.S. Moderate to severe periodic limb movements disorder in childhood and adolescence. Sleep 22 (1999) 297-300
33. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165 (2002) 1217-1239
34. Ali N.J., Pitson D.J., and Stradling J.R. Snoring, sleep disturbance, and behaviour in 4-5 year olds. Arch Dis Child 68 (1993) 360-366
35. Castronovo V., Zucconi M., Nosetti L., et al. Prevalence of habitual snoring and sleep-disordered breathing in preschool-aged children in an Italian community. J Pediatr 142 (2003) 377-382
36. Redline S., Tishler P.V., Schluchter M., et al. Risk factors for sleep-disordered breathing in children: associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 159 5 pt 1 (1999) 1527-1532
37. Kim J., In K., Kim J., et al. Prevalence of sleep-disordered breathing in middle-aged Korean men and women. Am J Respir Crit Care Med 170 (2004) 1108-1113
38. Foley D.J., Masaki K., White L., et al. Sleep-disordered breathing and cognitive impairment in elderly Japanese-American men. Sleep 26 (2003) 596-599
39. Peppard P.E., Young T., Palta M., et al. Longitudinal study of moderate weight change and sleep disordered breathing. JAMA 284 (2000) 3015-3021
40. Krell S.B., and Kapur V.K. Insomnia complaints in patients evaluated for obstructive sleep apnea. Sleep Breath 9 (2005) 104-110
41. Foresman B.H., Gwirtz P.A., and McMahon J.P. Cardiovascular disease and obstructive sleep apnea: implications for physicians. J Am Osteopath Assoc 100 (2000) 360-369
42. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Crit Care Med 165 (2002) 1217-1239
43. Marin J.M., Gascon J.M., Carrizo S., et al. Prevalence of sleep apnoea syndrome in the Spanish adult population. Int J Epidemiol 26 (1997) 381-386
44. Peker Y., Hedner J., Norum J., et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166 (2002) 159-165
45. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
46. Javaheri S., Parker T.J., Wexler L., et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 122 (1995) 487-492
47. Gami A.S., Pressman G., Caples S.M., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 110 (2004) 364-367
48. Peker Y., Kraiczi H., Hedner J., et al. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 14 (1999) 179-184
49. Marin J.M., Santiago J.C., Vicente E., et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
50. Guilleminault C., Tilkian A., and Dement W.C. The sleep apnea syndromes. Annu Rev Med 27 (1976) 465-484
51. Bassiri A.G., and Guilleminault C. Clinical features of evaluation of obstructive sleep apnea-hypopnea syndrome. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practices of sleep medicine. 3rd edition (2000), Saunders, Philadelphia 868-878
52. Guilleminault C., Do Kim Y., Chowdhuri S., et al. Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome. Eur Respir J 17 (2001) 838-847
53. Guilleminault C., Stoohs R., Clerk A., et al. A cause of excessive daytime sleepiness: the upper airway resistance syndrome. Chest 104 (1993) 781-787
54. Chervin R.D. Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest 118 (2000) 372-379
55. Gastaut H., Tassinari C.A., and Duron B. Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome. Brain Res 1 (1966) 167-186
56. Guilleminault C., van den Hoed J., and Mitler M. Clinical overview of the sleep apnea syndromes. In: Guillemininault C., and Dement W. (Eds). Sleep apnea syndromes (1978), Alan R Liss, New York 1-11
57. Bradley T.D., McNicholas W.T., Rutherford R., et al. Clinical physiological heterogeneity of the central sleep apnea syndrome. Am Rev Respir Crit Care Med 134 (1986) 217-221
58. Findley L.J., Zwillich C.W., Ancoli-Israel S., et al. Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 78 (1985) 11-15
59. Chesson A.L., Wise M., Davila D., et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. Sleep 22 (1999) 961-968
60. Ohayon M.M., and Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 53 (2002) 547-554
61. Kirk V.G., and Bohn S. Periodic limb movements in children: prevalence in a referred population. Sleep 27 (2004) 313-315
62. American Sleep Disorders Association. International classification of sleep disorders, revised: diagnostic and coding manual (1997), American Sleep Disorders Association, Rochester (MN)
63. Mendelson W.B. Are periodic leg movements associated with clinical sleep disturbance?. Sleep 19 (1996) 219-223
64. Chervin R.D. Periodic limb movements and sleepiness in patients evaluated for sleep-disordered breathing. Am J Respir Crit Care Med 164 8 pt 1 (2001) 1454-1458
65. Montplaisir J., Boucher S., Poirier G., et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome. Mov Disord 12 (1997) 61-65
66. Connor J.R., Boyer P.J., Menzies S.L., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61 (2003) 304-309
67. Allen R.P., Barker P.B., Wehrl F., et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 56 (2001) 263-265
68. Allen R.P., and Earley C.J. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 18 (2001) 128-147
69. Hublin C., Kaprio J., Partinen M., et al. The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort. Ann Neurol 35 (1994) 709-716
70. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 50 Suppl 1 (1998) S16-S22
71. US Xyrem in Narcolepsy Multi-center Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 25 (2002) 42-49
72. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
73. International Classification of Sleep Disorders (ICSD). Diagnostic and Coding Diagnostic Classification Steering Committee (Thorpy MJ, chairman). American Sleep Disorders Association. Narcolepsy 347 (1990) 38-43
74. Beusterien K.M., Rogers A.E., Walsleben J.A., et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 22 (1999) 757-765
75. Honda Y. Clinical features of narcolepsy: Japanese experiences. In: Honda Y., and Juji T. (Eds). HLA in narcolepsy (1988), Springer-Verlag, Berlin 24-57
76. Gelb M., Guilleminault C., Kraemer H., et al. Stability of cataplexy over several months: information for the design of therapeutic trials. Sleep 17 (1994) 265-273
77. Rogers A.E., Aldrich M.S., and Caruso C.C. Patterns of sleep and wakefulness in treated narcoleptic subjects. Sleep 17 (1994) 590-597
78. Overeem S., Mignot E., van Dijk J.G., et al. Narcolepsy: clinical features, new pathophysiological insights, and future perspectives. J Clin Neurophysiol 18 (2001) 78-105
79. Nishino S., Ripley B., Overeem S., et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (2000) 39-40
80. Mignot E., Lammers G.J., Ripley B., et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59 (2002) 1553-1562
81. Montplaisir J., and Poirier G. HLA in disorders of excessive sleepiness without cataplexy in Canada. In: Honda Y., and Juji T. (Eds). HLA in narcolepsy (1988), Springer-Verlag, Berlin 186
82. Montplaisir J., De Champlain J., Young S.N., et al. Narcolepsy and idiopathic hypersomnia: biogenic. amines and related compounds in CSF. Neurology 32 (1982) 1299-1302
83. Faull K.F., Guilleminault C., Berger P.A., et al. Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia. Ann Neurol 13 (1983) 258-263
84. Faull K.F., Thiemann S., King R.J., et al. Monoamine interactions in narcolepsy and hypersomnia: a preliminary report. Sleep 9 1 pt 2 (1986) 246-249
85. Billiard M., and Dauvillies Y. Idiopathic hypersomnia. Sleep Med Rev 5 (2001) 351-360
86. Roth B., Nevsimalova S., and Rechtschaffen A. Hypersomnia with "sleep drunkenness.". Arch Gen Psychiatry 26 (1972) 456-462
87. Critchley M. The syndrome of hypersomnia and periodical megaphagia in the adult male (Kleine-Levin): what is its natural course?. Rev Neurol 116 (1967) 647-650
88. Rosenow F., Kotagal P., Cohen B.H., et al. Multiple sleep latency test and polysomnography in diagnosing Kleine-Levin syndrome and periodic hypersomnia. J Clin Neurophysiol 17 (2000) 519-522
89. Arias M., Crespo Iglesias J.M., Perez J., et al. Klein-Levin syndrome: contribution of brain SPECT in diagnosis. Rev Neurol 35 (2003) 531-533
90. Billiard M., Guilleminault C., and Dement W.C. A menstruation-linked periodic hypersomnia: Kleine-Levin syndrome or a new clinical entity?. Neurology 25 (1975) 436-443
91. Sachs C., Persson H., and Hagenfeldt K. Menstruation-associated periodic hypersomnia: a case study with successful treatment. Neurology 32 (1982) 1376-1379
92. Bamford C.R. Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. Sleep 16 (1993) 484-486
93. Rothstein J.D., Guidotti A., Tinuper P., et al. Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor. Lancet 340 (1992) 1002-1004
94. Lugaresi E., Montagna P., Tinuper P., et al. Endozepine stupor: recurring stupor linked to endozepine-4 accumulation. Brain 121 pt 1 (1998) 127-133
95. Soriani S., Carrozzi M., De Carlo L., et al. Endozepine stupor in children. Cephalalgia 17 (1997) 658-661
96. Francisco G.E., and Ivanhoe C.B. Successful treatment of post-traumatic narcolepsy with methylphenidate: a case report. Am J Phys Med Rehabil 75 (1996) 63-65
97. Manni R., and Tantara A. Evaluation of sleepiness in epilepsy. Clin Neurophysiol 111 Suppl 2 (2000) S111-S114
98. Toth L.A., and Opp M.R. Sleep and infection. In: Lee-Chiong T.L., Sateia M.J., and Carskadon M.A. (Eds). Sleep medicine (2002), Hanley & Belfus, Philadelphia 77-83
99. Guilleminault C., and Mondini S. Mononucleosis and chronic daytime sleepiness: a long term follow-up study. Arch Intern Med 146 (1986) 1333-1335
100. Askenasy J.J.M. Sleep in Parkinson's disease. Acta Neurol Scand 87 (1993) 167-170
101. Chokroverty S. Sleep and degenerative neurologic disorders. Neurol Clin 14 (1996) 807-826
102. Trenkwalder C. Sleep dysfunction in Parkinson's disease. Clin Neurosci 5 (1998) 107-114
103. George C.F.P. Neuromuscular disorders. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine. 3rd edition (2000), Saunders, Philadelphia 1087-1092
104. Gibbs J.W., Ciafaloni E., and Radtke R.A. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep 25 (2002) 662-665
105. Campbell S.M., Clark S., Tindall E.A., et al. Clinical characteristics of fibrositis: I. a "blinded" controlled study of symptoms and tender points. Arthritis Rheum 26 (1983) 817-824
106. Hyyppa M.T., and Kronhom E. Nocturnal motor activity in fibromyalgia patients with poor sleep quality. J Psychosom Res 39 (1995) 85-91
107. Moldofsky H., Saskin P., and Lue F.A. Sleep and symptoms in fiborsitis syndrome after a febrile illness. J Rheumatol 15 (1988) 1701-1704
108. Moldofsky H., Lue F.A., and Smythe H. Alpha EEG sleep and morning symptoms of rheumatoid arthritis. J Rheumatol 10 (1983) 373-379
109. Perlis M.L., Giles D.E., Bootzin R.R., et al. Alpha sleep and information processing, perception of sleep, pain, and arousability in fibromyalgia. Int J Neurosci 89 (1997) 265-280
110. Moldolfsky H., and Lue F.A. The relationship of alpha delta EEG frequencies to pain and mood in "fibrositis" patients with chlorpromazine and L-tryptophan. Electroencephalogr Clin Neurophysiol 50 (1980) 71-80
111. Yamashiro Y., and Kryger M.H. Sleep in heart failure. Sleep 16 (1993) 513-523
112. Javaheri S., Parker T.J., Liming J.D., et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 97 (1998) 2154-2159
113. Brostrom A., Stromber A., Dahlsrom U., et al. Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs 19 (2004) 234-242
114. Davidson J.R., MacLean A.W., Brundage M.D., et al. Sleep disturbance in cancer patients. Soc Sci (Kans) 54 (2002) 1309-1321
115. Portenoy R.K., Tahler H.T., Kombilth A.B., et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3 (1994) 183-189
116. Vena C., Parker K., Cunningham M., et al. Sleep-wake disturbances in people with cancer: Part I. an overview of sleep, sleep regulation, and effects of disease and treatment. Oncol Nurs Forum 31 (2004) 735-746
117. Resta O., Paanacciulli N., Di Gioia G., et al. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis 14 (2004) 248-253
118. Blanco Perez J.J., Blanco-Ramos M.A., Zamarron Sanz C., et al. Acromegaly and sleep apnea. Arch Bronconeumol 40 (2004) 355-359
119. Rosenow F., Reuter S., Deuss U., et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endcroninol (Oxf) 45 (1996) 563-569
120. Bjork S., Jonsson B., Westphal O., et al. Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand Suppl 356 (1989) 55-59
121. Tylee A., Gastpar M., Lepine J.P., et al. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol 14 (1999) 139-151
122. Reynolds III C.F., Coble P.A., Kupfer D.J., et al. Application of the multiple sleep latency test in disorders of excessive sleepiness. Electroencephalogr Clin Neurophysiol 53 (1982) 443-452
123. Chesson Jr. A.L., Littner M., Davila D., et al. Practice parameters for the use of light therapy in the treatment of sleep disorders. Standards of Practice Committee, American Academy of Sleep Medicine. Sleep 22 (1999) 641-660
124. Czeisler C.A. Commentary: evidence for melatonin as a circadian phase-shifting agent. J Biol Rhythms 12 (1997) 618-623
125. Patel S.R., White D.P., Malhotra A., et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 163 (2003) 565-571
126. Morisson F., Decary A., Petit D., et al. Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Chest 119 (2001) 45-52
127. Allen R.P., and Early C.J. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 18 (2001) 128-147
128. Allen R., Becker P.M., Bogan P., et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 27 (2004) 907-914
129. Trenwalder C., Garcia-Borreguero D., Montagna P., et al. Ropinirole in the treatment of restless legs syndrome: results form the TREAT RLS1 study, a 12 week, randomized, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 75 (2004) 92-97
130. Mamelak M., Black J., Monplaisir J., et al. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 27 (2004) 1327-1334
131. Black J. Nightly administration of sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. [abstract]. Sleep 28 (2005) A218
132. Mitler M.M., Aldrich M.S., Koob G.F., et al. Narcolepsy and its treatment with stimulants. ASDA standards of practice. Sleep 17 (1994) 352-371
133. Wisor J.P., and Ericksson K.S. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132 (2005) 1027-1034
134. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 54 (2000) 1166-1175